“…Inside the cells, Mtb releases significant amounts of proteins and lipids, among them TMM, TDM, PIM, PGL, PE, phosphatidylglycerol, CL, and ManLAM, that traffic within the cell and may be released through exocytosis (Russell et al 2002;Russell 2011). These molecules are not only taken up by bystander antigen-presenting cells, they also act as modulators of the function of the host cell and surrounding tissue, impacting the secretion of pro-and anti-inflammatory cytokines (e.g., PGL, TDM, mycolic acids, SL, PIM, LM, ManLAM, and lipoproteins), apoptosis (lipoproteins, PIM, ManLAM, and TDM), T-cell functions (ManLAM, DAT, and PAT), the induction of foamy macrophages (oxygenated mycolates and TDM), and granuloma formation (TMM, TDM, and ManLAM) (Daffé and Draper 1998;Jackson et al 2007;Gilleron et al 2008;Peyron et al 2008;Guenin-Macé et al 2009;Neyrolles and Guilhot 2011;Rajni et al 2011;Russell 2011;Vander Beken et al 2011;Li et al 2012;Sakamoto et al 2013;Vir et al 2013). Importantly, several Mtb lipids, including diacylated forms of SL, PIM, ManLAM, MPM, and mycolyl lipids, represent themselves as antigens for immune recognition and are presented to T lymphocytes by MHC-I-like molecules of the CD1 family (Matsunaga and Sugita 2012;Arora et al 2013;Ly et al 2013;Van Rhijn et al 2013).…”